News | May 25, 2021
Glenmark receives ANDA approval for Icatibant Injection
This marks Glenmark's first synthetic decapeptide injectable approval
This marks Glenmark's first synthetic decapeptide injectable approval
DCGI-approved semaglutide syringes for diabetes and obesity expand treatment choices and improve affordability
An exploratory overall survival signal also leaned in favor of the combination, though the companies noted the result remains preliminary
Fertility platform launches flagship clinic with advanced IVF tech
The aflibercept biosimilar, referencing Eylea, becomes the company’s fifth directly commercialized biosimilar in Europe, expanding access to ophthalmology treatments
Lilly will acquire Curevo in a deal worth up to $1.5 billion in cash, including upfront and milestone-based payments.
The company said all doses achieved statistically significant reductions in body weight compared with placebo at 72 weeks
Pfizer says the broader dataset across all 25 serotypes strengthens confidence that the program can meet non-inferiority thresholds in its upcoming Phase 3 pediatric trials
The product has received tentative USFDA approval, Health Canada notice of compliance, and Indian regulatory approval
Dr. Reddy’s is the first company to receive Health Canada approval for generic Semaglutide Injection in Canada
Subscribe To Our Newsletter & Stay Updated
